| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 8, 2002
From the Department of Medicine, Tulane University School of
Medicine (J.C., J.H., L.H., V.B., P.K.W), and the Department of
Epidemiology, Tulane University School of
Public Health and Tropical Medicine (J.H., P.K.W.), New Orleans,
La. * To whom correspondence should be addressed. E-mail: jhe{at}tulane.edu.
AbstractSerum
vitamin C has been inversely associated with blood pressure in several
epidemiologic studies, but little is known about effect of other
antioxidant vitamins. We examined the relation between serum vitamins
A, C, and E,
Revised on May 2, 2002
Serum Antioxidant Vitamins and Blood Pressure in
the United States Population
Jing Chen;
-carotene, and ß-carotene levels and blood pressure
among 15 317 men and women
20 years of age who participated in the
Third National Health and Nutrition Examination Survey. Blood pressure
was characterized as the average of 6 measurements obtained over 2
visits by trained observers and hypertension was defined as blood
pressure
140/90 mm Hg and/or taking antihypertensive
medications. In multivariate models, a 1 SD difference
in vitamin A (16.2 µg/dL) and vitamin E (20.4 µg/dL) was associated
with a 43% (OR, 1.43; 95% CI, 1.34 to 1.53) and 18% (OR, 1.18; 95%
CI, 1.09 to 1.27) higher odds of hypertension, respectively. A 1 SD
difference in
-carotene (0.47 µg/dL) and ß-carotene (496
µg/dL) was associated with a 16% (OR, 0.84; 95% CI, 0.76 to 0.94)
and 11% (OR, 0.89; 95% CI, 0.82 to 0.97) lower odds of hypertension,
respectively. In addition, serum vitamins A and E were positively and
significantly associated with both systolic and
diastolic blood pressure, whereas
-carotene and
ß-carotene were inversely and significantly associated with
systolic and vitamin C associated with diastolic
blood pressure in multivariate linear regression
analyses. These findings indicate that antioxidant vitamins may
be important in the underlying cause and prevention of hypertension.
Further studies in this important area are
warranted.
This article has been cited by other articles:
![]() |
T. M. Paravicini and R. M. Touyz NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension: What Is the Clinical Significance? Hypertension, September 1, 2004; 44(3): 248 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Chiplonkar, V. V. Agte, K. V. Tarwadi, K. M. Paknikar, and U. P. Diwate Micronutrient Deficiencies as Predisposing Factors for Hypertension in Lacto-Vegetarian Indian Adults J. Am. Coll. Nutr., June 1, 2004; 23(3): 239 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rodriguez-Iturbe, N. D. Vaziri, J. Herrera-Acosta, and R. J. Johnson Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all Am J Physiol Renal Physiol, April 1, 2004; 286(4): F606 - F616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Taguchi Etiology of the Metabolic Syndrome JAMA, March 24, 2004; 291(12): 1443 - 1444. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |